Adi Reske

Executive Director, Scientific Communications, Medical Affairs at Mersana Therapeutics

Adi Reske, PhD has a diverse and extensive work experience in scientific communications, medical affairs, and competitive intelligence. They currently hold the position of Executive Director, Scientific Communications, and Medical Affairs at Mersana Therapeutics since January 2023. Prior to this role, they served as the Senior Director of Scientific Communications, Medical Affairs at Mersana Therapeutics and as the Senior Director of Product Strategy & Market Intelligence. Adi Reske also has experience as the Director of Pipeline Competitive Intelligence at Vertex Pharmaceuticals and as the Director of Portfolio Assessment/Competitive Intelligence at TESARO, Inc. They have previously held positions as a Senior Director at Fuld + Company, a Senior Business Insights Analyst at Decision Resources Group, and a Life Science Analyst at LifeTech Research. Their research experience includes a role as a Research Fellow at Harvard Medical School/Children's Hospital Boston, where they focused on the study of S. pneumoniae and the interaction between bacterial proteins and cells of the innate immune system. Adi Reske holds a PhD and was a PhD Candidate at University College London. They also have military experience as a Captain/Military Intelligence in the Israel Defense Forces and as a Research Assistant at the Division of Parasitology/Immunology at Kimron Veterinary Institute.

Adi Reske, PhD, obtained a BSc in Biology from The Hebrew University of Jerusalem. Adi later pursued an M.Sc in Immunology/Parasitology from the same institution. Moreover, they earned a PhD in Immunology from UCL.

Links

Previous companies

Boston Children's Hospital logo
Fuld + Company logo
Vertex Pharmaceuticals logo
TESARO logo

Org chart

Timeline

  • Executive Director, Scientific Communications, Medical Affairs

    January, 2023 - present

  • Senior Director, Scientific Communications, Medical Affairs

    October, 2021

  • Senior Director, Product Strategy & Market Intelligence

    September, 2019

View in org chart